Related Experiment Video
Updated: Jun 27, 2025

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by
David Ascheid1, Magdalena Baumann1, Jürgen Pinnecker2
1Institute of Anatomy and Cell Biology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Abstract:
Targeting the supportive tumor microenvironment (TME) is an approach of high interest in cancer drug development. However, assessing TME-targeted drug candidates presents a unique set of challenges. We develop a comprehensive screening platform that allows monitoring, quantifying, and ranking drug-induced effects in self-organizing, vascularized tumor spheroids (VTSs). The confrontation of four human-derived cell populations makes it possible to recreate and study complex changes in TME composition and cell-cell interaction. The platform is modular and adaptable for tumor entity or genetic manipulation. Treatment effects are recorded by light sheet fluorescence microscopy and translated by an advanced image analysis routine in processable multi-parametric datasets. The system proved to be robust, with strong interassay reliability. We demonstrate the platform's utility for evaluating TME-targeted antifibrotic and antiangiogenic drugs side-by-side. The platform's output enabled the differential evaluation of even closely related drug candidates according to projected therapeutic needs.
Insights
A new screening platform using vascularized tumor spheroids (VTSs) enables precise evaluation of cancer drug candidates targeting the tumor microenvironment (TME). This system reliably ranks drug efficacy for improved cancer therapy development.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- Targeting the tumor microenvironment (TME) is crucial in cancer drug development.
- Assessing TME-targeted drug candidates faces significant challenges.
- Existing methods lack the complexity to model TME interactions effectively.
Purpose of the Study:
- To develop a comprehensive screening platform for evaluating drug effects on the TME.
- To enable monitoring, quantification, and ranking of drug candidates.
- To facilitate the study of complex TME composition and cell-cell interactions.
Main Methods:
- Development of a screening platform using self-organizing, vascularized tumor spheroids (VTSs).
- Recreation of TME complexity using four human-derived cell populations.
- Utilizing light sheet fluorescence microscopy and advanced image analysis for data acquisition and processing.
Main Results:
- The platform demonstrated robustness and strong interassay reliability.
- Successfully enabled side-by-side evaluation of antifibrotic and antiangiogenic drugs.
- Facilitated differential evaluation of closely related drug candidates based on therapeutic needs.
Conclusions:
- The developed VTS screening platform offers a powerful tool for TME-targeted drug discovery.
- The system provides reliable, multi-parametric data for assessing drug efficacy.
- This platform can accelerate the development of novel cancer therapies by enabling precise drug candidate selection.

